IAVI Report 11 (3), May 2007 - June 2007
> Download a PDF file of this issue
Moving target
Establishing accurate estimates of HIV incidence rates are critical to the success of prevention trials
Perspective: HIV controllers
Can the Human Genome Project advance AIDS vaccine development?
One-two combination
Heterologous prime-boost is currently the regimen of choice for many AIDS vaccine approaches, even though exactly how it works is still far from clear